Navigation Links
Hyperion Therapeutics Elects Lota Zoth to Board of Directors
Date:4/7/2008

SOUTH SAN FRANCISCO, Calif., April 7, 2008 /PRNewswire/ -- Hyperion Therapeutics, Inc., a privately held biopharmaceutical company, today announced that Lota S. Zoth has been elected to the company's Board of Directors. Ms. Zoth formerly served as Senior Vice President and Chief Financial Officer of MedImmune, Inc. with oversight of finance, information technology and public affairs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

In discussing her appointment, Ms. Zoth commented, "Hyperion's co-promotion agreements and strong product pipeline make it a very attractive opportunity. I look forward to helping the Hyperion team continue to execute on its growth objectives."

Prior to MedImmune, Ms. Zoth was Chief Accounting Officer for PSINet, Inc. and Sodexho Marriott Services, Inc., both of which were publicly-held companies. She also served in various finance executive roles at Marriott International and PepsiCo, Inc. after spending almost a decade at Ernst & Young as an audit executive. Ms. Zoth is a certified public accountant and holds a bachelor's of business administration degree in accounting from Texas Tech University.

"Lota's extensive financial and operational background will be a valuable addition to our Board of Directors," said Chris Rivera, President and Chief Executive Officer of Hyperion Therapeutics, Inc. "We look forward to her contributions as we build out our financing strategies with an eye towards accessing the public markets."

About Hyperion Therapeutics

Hyperion Therapeutics is a fully-integrated specialty therapeutics company committed to becoming a global leader in the development and commercialization of hepatology and gastrointestinal therapies that address orphan or underserved patient populations with unmet medical needs. Hyperion's commercial operations division currently markets two product
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
2. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
3. Antisense therapeutics scientist out to pull more big deals
4. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
5. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
6. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
7. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
8. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
9. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
10. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
11. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
...ng anthocyanin molecules could lead to new treatme...) -- Compounds called anthocyanins, which give col...les, may help protect against colon cancer, an Ohi...y slow the growth of colon cancer cells. The team ...
...ors of cardiovascular trouble, study found , FRIDA...gs down a number of "biological indicators" pointi...y shows. , The indicators include autonomic dysfun...ory and Critical Care Medicine . , "This study pro...
... sleep routine at least a week before classes star...he new school year starts, youngsters should start...don,t, they could end up suffering a sleep deficit... once a schedule has been established, it may take...
...eposits of fat on the chest and back is associate...condition that is a precursor of type 2 diabetes, ... Francisco VA Medical Center (SFVAMC). , It is t... HIV negative control subjects in the Study of Fat...
...e now diagnosed as having depression? Two experts ...ordon Parker, a psychiatrist from Australia says t...clinical depression is too low. He fears it could...d 242 teachers. Fifteen years into the study, 79%...
...e (hypertension) is associated with an increased r...se of drugs known as NSAIDs, for example to treat ...ypertension. Exactly why NSAIDs cause hypertension...of inhibiting the individual receptors for prostag...
Other Medicine News:Health News:Urban Smog Tough on Young Adults' Hearts 2Health News:Add Earlier Bedtime to Back-to-School List 2Health News:Fat on chest and upper back increases risk of insulin resistance 2Health News:Are too many people diagnosed as 'depressed?' 2
(Date:12/4/2009)WINSTON-SALEM, N.C., Dec. 4 A new, $2.8 million, four-year federal grant will support researchers at the University of Pittsburgh School of Medicine and their collaborators at Wake Forest University
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Providing Comfort for Holiday Guests Just Got Easier 62103 1Providing Comfort for Holiday Guests Just Got Easier 62103 2Providing Comfort for Holiday Guests Just Got Easier 62103 3New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 1New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 3realbuzz com Top 25 Ways to Improve Your Health 26amp 3B get a Better Sex Life 21 62093 1realbuzz com Top 25 Ways to Improve Your Health 26amp 3B get a Better Sex Life 21 62093 2
...H SAN FRANCISCO, Calif., April 11, 2007 (PRIME NEW...rmaceutical company focused,on advancing cancer ca... (talotrexin) for Injection at the American Associ...il 14-18, 2007 in Los,Angeles, California. , Abstr...paclitaxel in A549 non-small cell lung cancer (NSC...
...EWATER, N.J.--(BUSINESS WIRE)--Apr 12, 2007 - Enzo...oday that four,posters containing preclinical data...he American Association for Cancer Research,(AACR)...s, CA., Details of the presentations are as follow...leneglycol-SN38,conjugate, has potent antitumor ac...
Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3Enzon to Present Preclinical Data From PEG-SN38 and PEGylation,Technology Studies at AACR Meeting 2
...stainer is an "assembly-line worker" for routine s...nd cytology laboratories. Programmable continuous ... stains big quantities of slides in short time. It...with a continuous working principle provides a hig...
Cholesterol (Single reagent)
Cholesterol Reagent Set
Omega 16ic
Medicine Products: